TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. scores highest on Anchor (66) and lowest on Price (1). Its PosiPenta is 35.27 out of 100, weaker than most similar companies.
On the Penta Grid this week, TriSalus Life Sciences, Inc. is Grid #661 of 837 in the Healthcare sector in United States, and Grid #3,280 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| TriSalus Life Sciences, Inc. | 35.27 | 1 | 57 | 47 | 4 | 66 |
| Keros Therapeutics, Inc. | 40.42 | 42 | 14 | 39 | 62 | 45 |
| SIGA Technologies, Inc. | 58.32 | 34 | 87 | 32 | 78 | 60 |
| Spok Holdings, Inc. | 64.44 | 65 | 68 | 52 | 72 | 66 |
| Greenwich LifeSciences, Inc. | 38.62 | 1 | 47 | 46 | 45 | 54 |
| Inhibikase Therapeutics, Inc. | 50.89 | 33 | 44 | 59 | 68 | 51 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.98 |
| P/B ratio | 34.12 |
EEarnings
| Trailing EPS | ₹-115.55 |
| Forward EPS | ₹-23.68 |
NNitro
| Price | 343.82 |
| 52-week high | 752.98 |
| 52-week low | 208.37 |
| Fall from 52-week high | 54.3% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 5.26 |
AAnchor
| Beta (price swings) | 0.47 |
| Market cap | ₹2,117 Cr |
| Insider holding | 33.96% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is TriSalus Life Sciences, Inc.'s PosiPenta score?
TriSalus Life Sciences, Inc.'s PosiPenta is 35.27 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does TriSalus Life Sciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, TriSalus Life Sciences, Inc. is Grid #661 of 837 in the Healthcare sector in United States, and Grid #3,280 of 4,000 in United States.
Which PosiPenta pillar is strongest for TriSalus Life Sciences, Inc.?
Anchor (stability and dividends), with a score of 66 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for TriSalus Life Sciences, Inc.?
Price (valuation), with a score of 1 out of 100: much weaker than most similar companies.
Has TriSalus Life Sciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.44 points, from 32.83 to 35.27.
PositoAI is for research and education only and is not investment advice.